FIELD: biotechnology. SUBSTANCE: invention relates to hybridomas producing. Hybridomas are prepared by fusion of lymphocytes obtained from mice immunized with human erythropoietin with myeloma. Hybridomas are deposited at N VSKK/P/634D, VSKK/P/635D, VSKK/P/636D and they produce monoclonal antibodies raised to human erythropoietin. Molecular mass of monoclonal antibodies is 160 kDa and they belong to IgG1 with light chains of κ type. Invention ensures to obtain hybridoma panels producing antibodies to independent antigenic determinants of human natural erythropoietin. EFFECT: hybridoma strains indicated above, production of antibodies. 7 cl, 2 dwg, 1 tbl
Authors
Dates
2000-06-20—Published
1998-12-09—Filed